PI
CELG

Pathlight Investors’s Celgene Corp CELG Stock Holding History

Pathlight Investors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$322K Buy
+3,681
New +$272K 0.27% 68

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pathlight Investors's CELG Position: Q4 2018 in Review

Pathlight Investors opened a new position in Celgene Corp (CELG) in Q4 2018: 3,681 shares worth $322K. The stake represents 0.27% of the portfolio and ranks #68 among its holdings.

1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Pathlight Investors held 3,681 shares of Celgene Corp worth $322K as of Q4 2018.
  • Celgene Corp was a new Pathlight Investors position in Q4 2018.
  • Celgene Corp made up 0.27% of Pathlight Investors's portfolio in Q4 2018, its #68 holding.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.